1. Improving health care systems by building ‘more Europe’

   • F. Antoñanzas
   • C. A. Juárez-Castelló
   • R. Rodríguez-Ibeas

   Editorial 23 March 2016 Pages: 787 - 789

2. Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries

   • Petra Baji
   • Manuel García-Goñi
   • Francesco Paolucci

   Original Paper 22 August 2015 Pages: 791 - 799

3. Exploring a new method for deriving the monetary value of a QALY

   • Carl Tilling
   • Marieke Krol
   • Werner Brouwer

   Original Paper Open access 20 August 2015 Pages: 801 - 809

   

4. Quality target negotiation in health care: evidence from the English NHS

   • Eleonora Fichera
   • Hugh Gravelle
   • Matt Sutton

   Original Paper 11 September 2015 Pages: 811 - 822

5. Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization

   • Conor Keegan
   • Conor Teljeur
   • Steve Thomas

   Original Paper 10 September 2015 Pages: 823 - 831

   

6. The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012

   • Frank R. Lichtenberg

   Original Paper Open access 05 September 2015 Pages: 833 - 854

   

7. Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin–paclitaxel

   • Oscar Arrieta
   • Pablo Anaya
   • Ana C. Polanco

   Original Paper 04 September 2015 Pages: 855 - 863

   

8. Unchained melody: revisiting the estimation of SF-6D values

   • Benjamin M. Craig

   Original Paper 10 September 2015 Pages: 865 - 873

   

9. Multiple sclerosis: relapses, resource use, and costs

   • A. J. Hawton
   • C. Green

   Original Paper 05 October 2015 Pages: 875 - 884

   

10. Overpaying morbidity adjusters in risk equalization models

    • R. C. van Kleef
    • R. C. J. A. van Vliet
    • W. P. M. M. van de Ven

    Original Paper Open access 29 September 2015 Pages: 885 - 895

11. Marginal revenue and length of stay in inpatient psychiatry

    • Mark Pletscher

    Original Paper 07 October 2015 Pages: 897 - 910

    

12. OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales

    • Nick Freemantle
    • Kristin Khalaf
    • Marcus Drake

    Original Paper Open access 19 October 2015 Pages: 911 - 921